Scinovex
articleTop 10% cited

SB-505124 Is a Selective Inhibitor of Transforming Growth Factor-β Type I Receptors ALK4, ALK5, and ALK7

Molecular Pharmacology · 2004 · Vol. 65(3) · pp. 744–752
TGF-β signaling in diseasesConnective Tissue Growth Factor ResearchBone Metabolism and DiseasesSMADSignal transductionKinaseTGF beta receptor 2ReceptorTransforming growth factorProtein kinase ACell biologyChemistryTransforming growth factor beta

MeSH terms

Receptor, Transforming Growth Factor-beta Type IAnimalsBenzamidesDioxolesDNA-Binding ProteinsDrug InteractionsHumansProteinsTumor Cells, CulturedTrans-ActivatorsTransforming Growth Factor betaCell DeathProtein Serine-Threonine KinasesGenes, ReporterReceptors, Transforming Growth Factor beta
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

SB-505124 Is a Selective Inhibitor of Transforming Growth Factor-β Type I Receptors ALK4, ALK5, and ALK7 · Scinovex